Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
Anika (NASDAQ: ANIK) announced that Steve Griffin, President and CEO, will present at the Canaccord Genuity 2026 Musculoskeletal Conference in New Orleans on March 2, 2026 at 11:30am CT / 12:30pm ET.
Rhea-AI Summary
Anika (NASDAQ: ANIK) announced that Steve Griffin, President and CEO, will present at the Canaccord Genuity 2026 Musculoskeletal Conference in New Orleans on March 2, 2026 at 11:30am CT / 12:30pm ET. Management will hold one-on-one investor meetings during the event.
The presentation will be webcast live on Anika's Events and Webcasts investor page and will be archived for 30 days. For meeting requests, contact investorrelations@anika.com.
Details
News Market Reaction – ANIK
On Feb 19, the first trading day after this news, ANIK closed 1.71% above the previous close.
Data tracked by StockTitan Argus for the Feb 19 session.
Key Figures
- Conference date
- March 2, 2026
- Canaccord Genuity 2026 Musculoskeletal Conference presentation date
- Presentation time CT
- 11:30am CT
- Scheduled time for ANIK presentation
- Presentation time ET
- 12:30pm ET
- Scheduled time for ANIK presentation
- Webcast archive period
- 30 days
- Webcast availability after the conference presentation
Historical Context
-
Announcement of upcoming Q4 and year-end 2025 results release and call.
-
Lumicell adds Anika’s Executive Chair to its board, highlighting her sector experience.
-
CEO transition to Steve Griffin with reaffirmed 2025 guidance and strategy focus.
-
Q3 revenue decline with OEM weakness despite commercial growth and cash generation.
-
Hyalofast Phase III missed co-primary endpoints but showed post-hoc secondary benefits.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Steve Griffin, President and CEO of Anika, will present at the Canaccord Genuity 2026 Musculoskeletal Conference in New Orleans on Monday, March 2, 2026 at 11:30am CT / 12:30pm ET. Management will also participate in one-on-one investor meetings throughout the event.
The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics’ website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at investorrelations@anika.com.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.